Skip to content

    UPL Limited

    UPL
    Chemicals·12 May 2025
    Management Summary

    UPL reported a strong recovery in FY25, achieving 8% revenue growth and 47% EBITDA growth, alongside robust free cash flow and significant debt reduction. The company's focus on operational excellence and differentiated product portfolio drove these results. While FY26 is anticipated to start slowly due to macro factors, UPL remains confident in its strategic direction and ability to outperform the industry.

    Highlights

    5

    • Revenue grew 8% YoY to ₹466.4 billion in FY25, reaching the upper end of guidance.

    • EBITDA grew 47% YoY to ₹81.2 billion in FY25, with EBITDA margins improving by 460 bps to 17.4%.

    • Free cash flow generation was $530 million (₹44.51 billion), exceeding the $300-400 million guidance.

    • Net debt reduced significantly by ₹83.3 billion ($1.04 billion) to ₹138.6 billion ($1.62 billion), resulting in a net debt to EBITDA ratio of 1.7x.

    • Working capital days reduced from 86 days in FY24 to 53 days in FY25, driven by inventory reduction and improved receivables collection.

    Concerns

    4

    • SG&A spend increased by 22% in Q4 FY25, partly due to bonus provisions and distributor delinquencies in Argentina.

    • An exceptional charge of ₹2.8 billion was recorded in Q4 FY25, largely attributed to a VAT provision in Brazil.

    • Losses from associated entities (Sinova and Origeo) increased to ₹4.72 billion in FY25 from ₹2.4 billion in the previous year.

    • Q1 and Q2 FY26 are expected to be subdued due to geopolitical turmoil and persistent low agricultural commodity prices.

    What Changed1

    vs Q1 FY26

    Guidance items7 → 13 (+6)
    Key financials

    Metrics

    10

    Periods

    3

    Q4 FY25

    4
    • Revenue
      $155.7B
      YoY+11%
    • EBITDA
      $32.4B
      YoY+68%
    • EBITDA Margin
      20.8%
    • Profit After Tax (Adj.)
      $9B

    FY25

    4
    • Revenue
      $466.4B
      YoY+8%
    • EBITDA
      $81.2B
      YoY+47%
    • EBITDA Margin
      17.4%
    • Free Cash Flow
      530 Mn

    FY25 end

    2
    • Net Debt
      $138.6B
    • Working Capital Days
      53 days

    Segment breakdown

    Global Crop Protection
    18% Revenue Growth (Q4 FY25)1000 bps EBITDA Margin Improvement (Q4 FY25)23% Differentiated & Sustainable Volume Growth (FY25)11% Differentiated & Sustainable Revenue Growth (FY25)38% Differentiated & Sustainable Mix (FY25)
    India Crop Protection (UPL SAS)
    6.8 billion Revenue (Q4 FY25)27.8% Contribution Margin (Q4 FY25)0.9 billion EBITDA (Q4 FY25)₹10,000 Cr Revenue (FY25)₹1,700 Cr Specialty Chemicals Revenue (FY25)₹370 Cr Specialty Chemicals EBITDA (FY25)
    Advanta (Seeds)
    12% Revenue Growth (FY25)11% EBITDA Margin (FY25)2.8 billion Valuation37% Revenue Growth (Q4 FY25)1.6% EBITDA Growth (Q4 FY25)
    Superform (Specialty Chemistries)
    6% Revenue Growth (FY25)24% Specialty Chemicals Revenue Growth (FY25)16% Specialty Chemicals EBITDA Growth (FY25)
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Debt

    Gross ₹237.1 billion · Net ₹138.6 billion · 1.7x EBITDA

    M&A

    Advanta shares (12.5% stake)

    divestment · closed · Consideration ₹NaN (cash)

    Liquidity

    Cash ₹98.6 billion

    Cash and bank balance increased significantly due to rights issue and Advanta share sale proceeds.

    Guidance & targets

    10
    CategoryTargetPriority
    Revenue
    Revenue Growth
    4% to 8%
    		Medium
    Revenue
    Natural Plant Protection Segment Revenue
    $700 million
    		High
    Revenue
    New Launches Revenue (India Crop Protection)
    ₹2 billion
    		High
    Profitability
    EBITDA Growth
    10% to 14%
    		Medium
    Product Mix
    Differentiated & Sustainable Segment Mix
    45-50%
    		High
    Product Mix
    Differentiated Portfolio Mix (India Crop Protection)
    40% to 45%
    		High
    Growth
    Sustainable Solution Segment CAGR
    13%
    		High
    Innovation
    Pipeline Value (Peak Sales)
    ~$4.3 billion
    		High
    Innovation
    Innovation Rate (India Crop Protection)
    >35%
    		High
    Market Share
    Europe Market Contribution (Advanta)
    15% to 20%
    		Medium

    FY26 Revenue Growth

    next quarter (Q1 FY26 results)
    Current8% (FY25)
    Target4-8% (FY26 guidance)

    Why it matters

    Key performance indicator, especially given the expectation of a subdued first half due to macro factors.

    So, considering all that, we are guiding for a revenue growth in the band of 4% to 8% and an EBITDA growth of about 10% to 14%.

    How to verify

    guidance_and_targets[category='Revenue']

    Risks & concerns

    5
    RiskSeverity

    Geopolitical Turmoil

    Expected to cause subdued performance in Q1 and Q2 FY26, leading to cautious guidance. — Management acknowledged

    high

    Low Agricultural Commodity Prices

    Expected to persist, resulting in flat to slightly lower profitability for farmers and impacting purchase patterns. — Management acknowledged

    medium

    Currency Volatility

    Presents a challenge, particularly in regions like LATAM, and is expected to cause some FX headwinds. — Management acknowledged

    medium

    Overcapacity from China

    Identified as a new market reality from FY24, requiring strategic adjustments to portfolio and operations. — Management acknowledged

    medium

    Distributor Delinquencies

    Impacted SG&A in Q4 FY25, particularly in Argentina, but treated as exceptional. — Management acknowledged

    low

    Q&A highlights

    8

    “So, the regions where we would likely to see a stronger growth in 4 to 8% would include North America, Latin America, and potentially the rest of the world region. ... our expectation is that the industry overall this year will be roughly flat. There'll be some volume growth and maybe a little bit of price degrowth.”

    Clarifies the drivers of the FY26 guidance, indicating a volume-led growth with some pricing pressure and regional variations.

    asked by Somaiah Valliyappan

    2 min read6 chapters

    Detailed Narrative

    01

    Strong FY25 Performance and Strategic Adjustments

    UPL reported a robust FY25, achieving 8% revenue growth to ₹466.4 billion and a significant 47% increase in EBITDA to ₹81.2 billion, with margins improving by 460 bps to 17.4%. This performance was driven by industry-leading volume growth of 13% across all regions and platforms. The company successfully navigated a challenging year by right-sizing its organization and focusing on a 'resilient core', leading to strong recovery in the second half.

    02

    Significant Debt and Working Capital Reduction

    The company demonstrated strong financial discipline, reducing gross debt by ₹47.2 billion ($635 million) to ₹237.1 billion ($2.77 billion) and net debt by ₹83.3 billion ($1.04 billion) to ₹138.6 billion ($1.62 billion). This was supported by a $250 million long-term loan prepayment and two capital transactions, including a rights issue and the partial monetization of Advanta shares for ₹30.4 billion ($350 million). Working capital days dramatically improved from 86 to 53, releasing ₹33.7 billion in cash.

    03

    Focus on Differentiated and Sustainable Solutions

    UPL is strategically shifting its portfolio towards differentiated and sustainable products, which currently account for 38% of its offerings and are targeted to reach 45-50% by FY27. These higher-margin products (600-1000 bps above post-patent) are expected to drive a ~13% CAGR between FY25 and FY30. New product launches contributed over $93 million in revenue in FY25, outperforming the $85 million target.

    04

    Advanta's Growth and European Expansion Strategy

    Advanta, UPL's seeds platform, achieved 12% revenue growth in FY25 and is now recognized as a top 10 global seed company with a $2.8 billion valuation. The company is focusing on expanding its presence in Europe, aiming to increase its market contribution from 2% to 15-20% by investing in unique germplasm like temperate corn. This expansion is supported by R&D efforts, including a planned shift of R&D activities to Hungary.

    05

    Superform: New Specialty Chemistries Platform

    UPL launched 'Superform', its newly branded Specialty Chemistries platform, leveraging 55 years of expertise. This platform aims to expand beyond agriculture into diverse applications such as pharma intermediates, mining, textile, and lubricants. In FY25, the specialty chemicals business grew 24% in revenue to ₹1,700 crores and 16% in EBITDA to ₹370 crores, demonstrating strong potential for value creation.

    06

    Cautious FY26 Outlook Amidst Geopolitical Headwinds

    For FY26, UPL provided guidance of 4-8% revenue growth and 10-14% EBITDA growth. Management indicated that Q1 and Q2 are expected to be subdued due to ongoing geopolitical turmoil and persistent low agricultural commodity prices. Despite these challenges, the company expressed confidence in its ability to outperform the industry and maintain focus on margin improvement and operational efficiencies.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.